Payments to Acquire Property, Plant, and Equipment of Esperion Therapeutics, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Esperion Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Esperion Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Esperion Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $0, a 100% decline from 2024.
  • Esperion Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $317,000.
  • Esperion Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $0.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Esperion Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 -$317,000 -100% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $317,000 +$317,000 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $0 $0 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2026 2025 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025 2024 FY
2021 $0 -$869,000 -100% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2022 2021 FY
2020 $869,000 -$84,000 -8.8% 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2022 2021 FY
2019 $953,000 +$802,000 +531% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
2018 $151,000 +$132,000 +695% 01 Jan 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
2017 $19,000 -$75,000 -80% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $94,000 -$231,000 -71% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $325,000 -$548,000 -63% 01 Jan 2015 31 Dec 2015 10-K 20 Feb 2018 2017 FY
2014 $873,000 +$842,000 +2716% 01 Jan 2014 31 Dec 2014 10-K 22 Feb 2017 2016 FY
2013 $31,000 +$24,000 +343% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $7,000 -$26,635 -79% 01 Jan 2012 31 Dec 2012 10-K 10 Mar 2015 2014 FY
2011 $33,635 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY

Esperion Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$73,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $73,000 +$73,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $0 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2021 $0 -$191,000 -100% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q1 2020 $191,000 +$2,000 +1.1% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $189,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2017 $14,000 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2015 $7,000 -$266,000 -97% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2014 $273,000 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.